XOMA 10K 2011 Annual report | XOMA Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abbot, abuse, accreted, ACE, ACEON, ADAPT, affirmative, Aldosterone, allosteric, allosterically, alter, American, amlodipine, Anergen, angiotensin, Annex, annum, antihypertensive, appendix, ARB, arginine, Aryx, asthma, BA, Baker, baseline, bellwether, besylate, Biofarma, biophysical, Bioscience, Blair, branded, breast, Brovana, calcium, cancel, cancellation, category, CDR, channel, charter, cholesterol, Circuit, colchicine, condensed, coordinated, coronary, CRP, cure, Daiichi, damage, Davidson, defraud, Demurrer, device, DGCL, diastolic, differential, diligent, Diovan, dismissed, distinct, diuretic, Eastern, Elan, elevated, Endocrinology, endpoint, enzyme, epidermal, erbumine, erosive, exert, expenditure, eye, false, FDC, Felix, FEOMA, ficlatuzumab, follicular, Funxional, Futhermore, GECC, gefitinib, genericized, Genset, gevokizumab, glycemic, gouty, guarantor, Guerrero, Harwell, HDL, Hematologic, hematological, HFA, HHSN, Hilditch, HIPAA, HITECH, homeostatic, hormone, hypertension, IgG, Immunology, imprisonment, inappropriate, incorrect, inhibitor, insolvency, insulin, intermediate, Introduction, Julian, knowingly, Krawiec, lipoprotein, lisinopril, longest, Lotrel, LP, lucatumumab, Lunesta, LUVENIQ, Lux, mandatory, marker, Marsh, Medicaid, Medicare, Medpace, merging, metabolic, metastatic, mice, Michigan, moderate, ModulX, mouse, Muniz, mutant, mycophenalate, Myfortic, NDA, Neurex, NIU, noncompliance, nonowner, Occidental, Onondaga, ophthalmic, OptimX, OrbiMed, organizational, Ortiz, Parent, PATH, Paul, perindopril, Pharmacology, pharmacovigilance, Physician, play, Portability, posterior, postpone, prejudice, Prinivil, privacy, prolactin, prominence, prominent, prostate, qui, rapamycin, reactive, recalled, recover, referral, reformatting, refractory, relief, relinquish, remedy, remuneration, Renin, reproduce, resistance, Resolvyx, retirement, Royal, RSU, Rubin, Rush, salt, Sankyo, Santen, scheme, secondarily, secondary, Sepracor, seventy, sharpen, sitting, sodium, soliciting, solid, spot, statute, stockholder, streamlining, stroke, succeeding, Sunshine, Supreme, surrender, Sylvia, systolic, tam, Tarka, telecommunication, tenure, terrorism, Teva, Tifenthal, transmission, triple, unannounced, unregistered, valsartan, Varian, voclosporin, war, warehouse, Western, White, willingly, Wisconsin, XMet, XMetA, Xopenex, yeast, ZESTRIL, zilueton

Removed: AB, accrual, affiliate, Alexion, augment, Avecia, bankruptcy, batch, biomedical, Bioshield, biotech, book, bring, career, Chapter, chose, Continuance, contrary, Dealer, decided, delisted, depending, designated, dilute, disclosed, domicile, EMEA, enforcement, entertain, eradication, exchanged, extending, extreme, FASB, Force, formalized, fragment, fulfillment, gastrointestinal, gel, Genome, globulin, herewith, history, impetigo, inconclusive, increasing, installment, introduced, irrevocably, irritation, Jolla, La, lab, leadership, Memorandum, Micro, nation, netted, overnight, peptide, perpetual, PharmAthene, plant, predecessor, predicated, prejudicial, rank, ratio, reevaluate, refinancing, reformulate, reformulated, reorganization, resulted, revised, skin, slightly, SNAPsSM, spend, spent, Stanford, suited, superficial, Taligen, Task, temporarily, topical, treaty, typical, unamortized, unproven, unutilized, update, utilization, vehicle

Subsidiaries of the Company	Jurisdiction of Organization
XOMA Ireland Limited	Ireland
XOMA Technology Ltd.	Bermuda
XOMA (US) LLC	Delaware
XOMA LS Limited	Ireland
XOMA CDRA LLC	Delaware

XOMA (XOMA) 10-K2011 FY Annual report

Content analysis